ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

CCOP Recompetition Approved, “Institutionalized;” Board Okays Concept For Eight Minority CCOPs

February 3, 1989

Letter In Response To Hadley; RFA Available

July 7, 1995

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013